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Open Biology’s first few months
Meeting the needs of researchers
When we launched Open Biology late last year, our goal was to offer a high-
quality, open access journal that met the needs of scientific researchers
working in biology at the molecular and cellular level. I feel that we are well
on our way to achieving this goal and wish to update you on the progress
we have made so far.
Open Biology’s mission is to provide a service that actively meets the needs
of biologists with cellular and molecular interests. This includes providing a
rapid, constructive and fair peer review system that allows valuable work to
proceed quickly to publication. At the launch event, the President of the
Royal Society, Paul Nurse, succinctly summarized the essence of our ethos:
This new journal will be run by scientists for scientists with an editorial system that
will be making decisions rather than weighing opinion.
I have been extremely encouraged by the feedback I have received from our
authors so far, who have commented on the speedy turnaround, excellent
reviews and decisive handling of the papers by Editors who provide construc-
tive, scientific input.
Open biology so far ...
The challenge with a new journal is to build and maintain momentum. Since
launching, we have published a relatively small number of articles. However,
I am very pleased with the quality and potential impact of the articles
published so far. In these first few months, we have published papers that
cover such diverse topics as the structural biology of the transketolase from
Mycobacterium tuberculosis, a novel drug target for the treatment of tuberculosis
[1], to the mathematical modelling of START, the point at which a yeast cell
becomes committed to undertake a new cell division cycle [2].
Of particular interest is an elegant report from Mariann Bienz’ laboratory
that uses Drosophila as a model to study how the Adenomatous polyposis coli
(APC) tumour suppressor enables Axin to promote the degradation of the
Wnt signalling effector b-catenin [3]. By examining apc null mutant Drosophila
tissues, they discovered parallels with APC mutant human tumour cells in
attenuating Axin degradasomes assembly. Their results suggest that APC
both promotes Axin to assemble into degradosomes and also opposes its
inactivating interaction with Dishevelled.
Dario Alessi and Miratul Muqit at the MRC Protein Phosphorylation Unit in
Dundee sent us their study on the mutation of PINK1 kinase in Parkinson’s
disease [4]. This field has been plagued by the low activity of the human
enzyme. To get around this, they have developed a system to use the
insect counterparts of PINK1 kinase to examine the consequences of known
disease-associated mutations in the enzyme.
We also attracted a very exciting report from Mitsuhiro Yanagida’s group
about condensin, a chromosome-associated protein whose diverse roles are
poorly understood. Their study suggests that condensin can unwind DNA
to allow proteins such as the replication protein A to be removed from
chromosomes after DNA repair and before the onset of mitosis [5].
Another fascinating study came from Neil Barclay and colleagues who
examined the stability of a disulphide bond in CD132, part of the receptor
for the cytokines, interleukins-2 and -4 [6]. Enzymes secreted during immune
activation can reduce this bond leading to inhibition of STAT-5 signalling
& 2012 The Authors. Published by the Royal Society under the terms of the Creative Commons Attribution
License http://creativecommons.org/licenses/by/3.0/, which permits unrestricted use, provided the original
author and source are credited.and of proliferation of a T-cell clone. Interestingly, mutants in
these residues lead to immunodeficiency in humans.
I am grateful to these and all of our authors for sending
the results of their labours to us. I am also indebted to the
work of the Subject Editors, Editorial Board and Royal
Society Editorial Office in handling submission, peer review
and publication in a timely manner. One priority is to get
Open Biology indexed in the appropriate databases, the most
important of which is PubMed. In order for PubMed to evalu-
ate a new journal, they need a minimum number of
published articles and I am pleased to report that we are to
make our submission for inclusion very soon. In addition, I
can confirm that we are already being tracked for inclusion
in Web of Science and Journal Citation Reports.
Open access
By launching Open Biology, the Society continues to demon-
strate its support for open access publishing. The journal
will be funded by charges for articles accepted for publi-
cation. Since launch, we have offered a promotional waiver
for these charges. However, in order to make publication sus-
tainable, these charges will apply for accepted papers
submitted from 1 March. I would like to take this opportunity
to explain a little about how this works.
The Society has set a price of £1200 for the article
processing charge. This charge covers the costs of peer
review, composition, hosting and archiving. While the
charge is slightly higher than some other open access
journals, it is linked to the fact that Open Biology is a selec-
tive journal with a relatively high rejection rate. Therefore,
this price reflects the fact that we are accepting (and therefore
charging for) a lower proportion of articles than less-selective
journals.
Another means of funding open access publication is
institutional open access membership. Such memberships
allow institutions to pay an annual fee and in return research-
ers at the institution receive a discount to the article
processing charge. The Royal Society has recently launched
membership programmes for all its journals, including
Open Biology. It has received a positive reception and a
number of key institutions have already signed up. I am
encouraged by this move by institutions to support open
access and benefit their authors by lowering the financial
barrier for publication.
Moving forward
It is still very early days for Open Biology, but I am encour-
aged by its reception in the scientific community and I
welcome your feedback. The Royal Society has a long
record of scientific publishing, originating with its oldest
journal, Philosophical Transactions, which spans three and a
half centuries (http://trailblazing.royalsociety.org/). I feel
confident that we can add to this rich history in this very
latest forum for communication between scientists. I would
like to encourage all of my fellow biologists to join with us
in making our newest journal an equal success.
Professor David Glover FRS, Editor-in-Chief and Subject Editor
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